Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Seminars in Cancer Biology|May 14, 2013
Genetic aberrations of signaling pathways in lymphomagenesis: revelations from next generation sequencing studiesDavide Rossi, Carmela Ciardullo, Gianluca Gaidano
Immunology Letters|October 10, 2013
Molecular bases of chronic lymphocytic leukemia in light of new treatmentsDavide Rossi, Carmela Ciardullo, Valeria Spina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2025
Early ctDNA dynamics inform first-line therapy in patients with extensive-stage small cell lung cancerCarmela Ciardullo, Luis Tobalina, T Hedley Carr, et al.
International Journal of Molecular Sciences|February 11, 2023
Splicing Modulation Results in Aberrant Isoforms and Protein Products of p53 Pathway Genes and the Sensitization of B Cells to Non-Genotoxic MDM2 InhibitionErhan Aptullahoglu, Carmela Ciardullo, Jonathan P Wallis, et al.
Haematologica|April 21, 2019
Non-genotoxic MDM2 inhibition selectively induces a pro-apoptotic p53 gene signature in chronic lymphocytic leukemia cellsCarmela Ciardullo, Erhan Aptullahoglu, Laura Woodhouse, et al.
International Journal of Molecular Sciences|October 21, 2020
DAP Kinase-Related Apoptosis-Inducing Protein Kinase 2 (DRAK2) Is a Key Regulator and Molecular Marker in Chronic Lymphocytic LeukemiaKatarzyna Szoltysek, Carmela Ciardullo, Peixun Zhou, et al.
Cancers|January 11, 2022
Low BACH2 Expression Predicts Adverse Outcome in Chronic Lymphocytic LeukaemiaCarmela Ciardullo, Katarzyna Szoltysek, Peixun Zhou, et al.
Blood|February 7, 2014
Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemiaDavide Rossi, Hossein Khiabanian, Valeria Spina, et al.
British Journal of Haematology|November 25, 2015
Inter- and intra-patient clonal and subclonal heterogeneity of chronic lymphocytic leukaemia: evidences from circulating and lymph nodal compartmentsIlaria Del Giudice, Marilisa Marinelli, Jiguang Wang, et al.
Pageof 2